Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15:42 | Tivic Health stock soars as company advances military radiation countermeasure | 3 | Investing.com | ||
15:34 | Tivic Health: Aktie schießt nach Fortschritten bei militärischem Strahlenschutz in die Höhe | 2 | Investing.com Deutsch | ||
02:06 | Tivic Health signals exit from consumer health tech while advancing $19B+ immunotherapy market pipeline | 3 | Seeking Alpha | ||
Do | Earnings Call: Tivic Health meldet für Q2 2025 Umsatzrückgang und strategische Neuausrichtung | 1 | Investing.com Deutsch | ||
Do | Tivic Health Systems, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
08.08. | Tivic Health registers 400K shares for resale linked to Statera License deal | 5 | Seeking Alpha | ||
25.07. | Tivic Health Systems, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
25.07. | Tivic Health Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
08.07. | Tivic Health stock rises after shareholders approve strategic proposals | 1 | Investing.com | ||
07.07. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
25.06. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
06.06. | Tivic Health Systems files to sell 8.44M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
06.06. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
22.05. | Tivic Health Systems, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
16.05. | Tivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioning | 1 | Seeking Alpha | ||
15.05. | Tivic Health Systems, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
14.05. | Tivic Health partners with Scorpius for drug manufacturing | 3 | Investing.com | ||
14.05. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | Tivic adds new vagus nerve stim patent | 1 | MassDevice | ||
09.05. | Tivic Health Systems files to sell 292,523 shares of common stock for holders | 3 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,118 | -0,84 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,699 | +3,56 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update | FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required
Strong... ► Artikel lesen | |
PING AN HEALTHCARE | 1,690 | +5,30 % | HSI Closes Midday at 24,929, Up 22 pts; HSTI Closes Midday at 5,438, Down 21 pts; KUAISHOU-W Down over 6%; CH MODERN D, BRILLIANCE CHI, YOURAN DAIRY, PA GOODDOCTOR, REALORD GROUP Hit New Highs | ||
MOUNTAIN VALLEY MD | 0,015 | +13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,268 | +17,54 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
CYTOSORBENTS | 0,950 | -2,56 % | Cytosorbents outlines DrugSorb ATR regulatory appeals and targets core business breakeven as German reorganization drives 22% sales growth | ||
VERU | 3,920 | +9,19 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA8959792018 Trilogy AI Corp. 08.08.2025 CA88909Q1090 Tokenwell Platforms Inc. 11.08.2025 Tausch 1:1US92536C1036 Veru... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,700 | +12,45 % | VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Aug. 14, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
EKSO BIONICS | 3,130 | -0,63 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 5,530 | -3,15 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
BEYOND AIR | 2,300 | -0,43 % | Beyond Air stock price target slashed by Piper Sandler to $5 from $20 | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,488 | +4,61 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR | ||
AROVELLA THERAPEUTICS | 0,058 | +9,52 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |